Noam Levin

National Institutes of Health — United States

Medicine · Health Sciences

11h-index1.3kcitations41works8.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

CAR-T cell therapy research(36), Cancer Immunotherapy and Biomarkers(14), Virus-based gene therapy research(13), Immunotherapy and Immune Responses(11), Immune Cell Function and Interaction(7)

Publications41 total

Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
Cancer Immunology Immunotherapy·2025Open Access
Selective expansion of T-cell receptor engineered T cells with increased stem-like phenotypes using neoantigen stimulation
Journal for ImmunoTherapy of Cancer·2025Open Access
333 Neoantigen-specific stimulation for selective expansion of T-cell receptor engineered T cells with increased naïve or stem-like phenotypes
Regular and Young Investigator Award Abstracts·2025Open Access
375  <i>KLF2</i> -overexpression imparts stemness onto dysfunctional neoantigen-reactive human tumor-infiltrating lymphocytes
Regular and Young Investigator Award Abstracts·2025Open Access
Utilization of primary tumor samples for cancer neoantigen discovery
Journal for ImmunoTherapy of Cancer·2025· 3 citedOpen Access
405 Identification of HLA class II-restricted T cell receptors against shared PIK3CA mutations in patients with epithelial cancers
Regular and Young Investigator Award Abstracts·2024Open Access
344 Drug-regulatable, inducible, and membrane-bound interleukin 12 (IL-12TM-D) for use in adoptive cell therapies against advanced cancers
Regular and Young Investigator Award Abstracts·2024Open Access
367 CD8 coreceptor dependence in HLA class I neoantigen-targeted TCR therapy
Regular and Young Investigator Award Abstracts·2024Open Access
Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results
Nature Medicine·2024· 62 cited
Neoantigen-specific stimulation of tumor-infiltrating lymphocytes enables effective TCR isolation and expansion while preserving stem-like memory phenotypes
Journal for ImmunoTherapy of Cancer·2024· 27 citedOpen Access
Adoptive transfer of T lymphocytes retrovirally transduced to express personalized neoantigen reactive T cell receptors can mediate tumor regression in patients with metastatic colorectal cancer
2024Open Access
Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
Cancer Cell·2023· 69 citedOpen Access
Adoptive Transfer of T Cells Genetically Engineered to Express T-Cell Receptors Targeting Neoantigens Arising from p53 and Ras Hotspot Mutations in Hematologic Malignancies
Blood·2023Open Access
366 Neoantigen-specific stimulation of T cells for effective cancer adoptive cell therapies
Regular and Young Investigator Award Abstracts·2023· 1 citedOpen Access
1216 Phenotypic signatures of circulating neoantigen-reactive CD8+ T cells in patients with metastatic cancers
Regular and Young Investigator Award Abstracts·2023Open Access
Data from Identification and Validation of T-cell Receptors Targeting &lt;i&gt;RAS&lt;/i&gt; Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting &lt;i&gt;RAS&lt;/i&gt; Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting &lt;i&gt;RAS&lt;/i&gt; Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting &lt;i&gt;RAS&lt;/i&gt; Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
Supplementary Data from Identification and Validation of T-cell Receptors Targeting &lt;i&gt;RAS&lt;/i&gt; Hotspot Mutations in Human Cancers for Use in Cell-based Immunotherapy
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Steven A. Rosenberg(33), Frank J. Lowery(30), Sanghyun P. Kim(30), Maria R. Parkhurst(27), Jared J. Gartner(25), Paul F. Robbins(25), Satyajit Ray(24), Zhiya Yu(21), Nolan R. Vale(20), Lien T. Ngo(19), Stephanie L. Goff(19), Sri Krishna(18), Biman C. Paria(18), Nikolaos Zacharakis(17), Maria Florentin(17), Sivasish Sindiri(16), Todd D. Prickett(15), Victoria Hill(13), Shoshana T. Levi(13), Rami Yossef(12)